scispace - formally typeset
D

David C. Evans

Researcher at Merck & Co.

Publications -  28
Citations -  2333

David C. Evans is an academic researcher from Merck & Co.. The author has contributed to research in topics: Microsome & Metabolite. The author has an hindex of 23, co-authored 28 publications receiving 2247 citations.

Papers
More filters
Journal ArticleDOI

Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.

TL;DR: This paper serves to provide one pragmatic approach to addressing the issue of bioactivation from an industry viewpoint based on protocols adopted by Merck Research Laboratories.
Journal ArticleDOI

Derivatization of ethinylestradiol with dansyl chloride to enhance electrospray ionization: application in trace analysis of ethinylestradiol in rhesus monkey plasma.

TL;DR: The facile dansyl derivatization coupled with tandem mass spectral analysis allowed the development of a highly sensitive and specific method for quantitation of trace levels of EE in the plasma of rhesus monkeys dosed orally and intravenously with EE.
Journal ArticleDOI

Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide.

TL;DR: Findings may have general implications in the use of total (free + conjugated) oxidative metabolite excretion for determining primary routes of drug clearance and may question the utility of diclofenac as a probe for phenotyping human CYP2C9 activity in vivo via measurement of its pharmacokinetics and total 4′-hydroxydicl ofenac urinary excretion.
Journal ArticleDOI

Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation.

TL;DR: Data indicate that P450 3A4-mediated bioactivation of raloxifene in vitro is accompanied by loss of enzyme activity, which is effective in the treatment of osteoporosis in postmenopausal women.
Journal ArticleDOI

Higher throughput bioanalysis by automation of a protein precipitation assay using a 96-well format with detection by LC-MS/MS.

TL;DR: Generic methodology for the automated preparation and analysis of drug levels in plasma samples within a drug discovery environment was achieved through the redesign of a protein precipitation assay to a microtiter plate format and the application of robotic liquid handling for performance of all transfer and pipetting steps.